TrialJAMA2014

Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial.

Alan W Heldman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.